AVIR earnings: real EPS beat/miss history, analyst consensus Hold, P/E -2.28. Updated 2026-07-23.
Atea Pharmaceuticals (AVIR) Research Hub
Atea Pharmaceuticals (AVIR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 5.31 USD (+0.76%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.28, market cap 0.38B. This hub links to the full technical, earnings and options research available for AVIR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.31 USD (+0.76%) |
| 52-week range | 3.82 USD – 5.9 USD |
| Trend regime | Range |
| 14-day RSI | 51.4 (Neutral) |
| Trailing P/E | -2.28 |
| Market cap | 0.38B |
| Dividend yield | 0.00% |
Available research for AVIR
Covered Call on AVIR: how it works, illustrative setup around the real 5.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AVIR: how it works, illustrative setup around the real 5.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AVIR: how it works, illustrative setup around the real 5.31 USD price, max profit/loss, breakeven and when to use it. Educational.
AVIR technical analysis: range, last 5.31 USD, RSI 51.4, 52w range 3.82 USD–5.9 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is AVIR in?
Atea Pharmaceuticals (AVIR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is AVIR in an uptrend or downtrend?
As of 2026-09-11, AVIR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AVIR's trailing P/E ratio?
AVIR's trailing P/E is -2.28, with a market cap of 0.38B. See the earnings research page for full valuation detail.